RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $126,000 | +9.6% | 11,353 | 0.0% | 0.23% | +34.1% |
| Q2 2019 | $115,000 | +71.6% | 11,353 | 0.0% | 0.17% | +86.8% |
| Q1 2019 | $67,000 | -17.3% | 11,353 | 0.0% | 0.09% | -48.9% |
| Q4 2018 | $81,000 | 0.0% | 11,353 | 0.0% | 0.18% | -7.8% |
| Q3 2018 | $81,000 | +28.6% | 11,353 | -10.0% | 0.19% | +40.9% |
| Q2 2018 | $63,000 | -54.7% | 12,615 | 0.0% | 0.14% | -49.8% |
| Q1 2018 | $139,000 | -40.3% | 12,615 | -50.0% | 0.27% | +35.1% |
| Q4 2017 | $233,000 | +2.6% | 25,231 | 0.0% | 0.20% | -1.0% |
| Q3 2017 | $227,000 | +28.2% | 25,231 | 0.0% | 0.20% | +25.9% |
| Q2 2017 | $177,000 | -59.9% | 25,231 | -50.0% | 0.16% | -50.5% |
| Q1 2017 | $441,000 | +37.0% | 50,463 | +26.2% | 0.33% | +27.2% |
| Q4 2016 | $322,000 | – | 40,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |